Clinical Trial Update: Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating everolimus as rescue immunosuppression for chronic allograft dysfunction in renal transplant recipients; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Dysfunction

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Allograft Dysfunction in Renal Transplantation | Phase 4 | Status: COMPLETED